Argiris Symeonidis

9.0k citations

179 papers · 2.4k indexed · h-index 25

Impact in

Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 125
- Acute Myeloid Leukemia Research 63
- Multiple Myeloma Research and Treatments 48
- Hematopoietic Stem Cell Transplantation 15
Genetics 67
- Hemoglobinopathies and Related Disorders 31
- Chronic Lymphocytic Leukemia Research 19
- Myeloproliferative Neoplasms: Diagnosis and Treatment 19

Co-authors: Meletios Α. Dimopoulos Evangelos Terpos Nicholas Zoumbos Eirini Katodritou Anastasia Pouli Konstantinos Zervas Dimitra Gika Nikolaos Anagnostopoulos
Journals: Blood (50 papers)Leukemia Research (16 papers)European Journal Of Haematology (6 papers)Acta Haematologica (5 papers)American Journal of Hematology (5 papers)
Partner nations: Greece Italy France

In The Last Decade

Argiris Symeonidis

166 papers receiving 2.4k citations

Peers

Countries citing papers authored by Argiris Symeonidis

Since Specialization

Citations

This map shows the geographic impact of Argiris Symeonidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Argiris Symeonidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Argiris Symeonidis more than expected).

Fields of papers citing papers by Argiris Symeonidis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Argiris Symeonidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Argiris Symeonidis. The network helps show where Argiris Symeonidis may publish in the future.

Co-authors

The 25 scholars most cited alongside Argiris Symeonidis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Argiris Symeonidis Line = papers co-authored together Argiris Symeonidis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Integrating advanced analytical methods to assess epigenetic marks affecting response to hypomethylating agents in higher risk myelodysplastic syndrome Molecular Medicine ·淳郎小山, Septianto Bambang, Maida Lynn Chen, Masashi Michibuchi, Ting Sun, 泰正田口, Рая Бабакулова, Kyriakos Bourikas, George P. Patrinos, Argiris Symeonidis, Argyro Sgourou	2025	0
2	Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee Blood ·Francesco Onida, Nico Gagelmann, Yves Chalandon, Guido Kobbe, Marie Robin, Argiris Symeonidis, Théo de Witte, Raphaël Itzykson, Madlen Jentzsch, Uwe Platzbecker, Valeria Santini, Guillermo Sanz, Christof Scheid, Éric Solary, Peter Valent, ACUÇENA GONÇALVES MOURA, Isabel Sánchez‐Ortega, Ibrahim Yakoub‐Agha, Lisa Pleyer	2024	8
3	Real-Life Multicenter Experience of Venetoclax in Combination with Hypomethylating Agents in Previously Untreated Adult Patients with Acute Myeloid Leukemia in Greece Journal of Clinical Medicine ·Maida Lynn Chen, Hakim Hakimakrab voila.Fr Akrab, T Kluensner, Kabir Sharma, Karli Woods, د . دعاء الفجر محمد سامی, Alice Currie Harding, Maria Kotsopoulou, Argiris Symeonidis, Maria Pagoni, Vasiliki Pappa, Sotirios G. Papageorgiou	2024	2
4	Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide‐exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA American Journal of Hematology ·Evangelos Terpos, Ioannis Ntanasis‐Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, 黄向明, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios Α. Dimopoulos	2024	10
5	Lower-Risk Myelodysplastic Syndrome (MDS) Patients Exhibit Diminished Proteasome Proteolytic Activity and High Intracellular Reactive Oxygen Species (ROS) Levels Cureus ·長屋昌宏, Dmitry Viktorovich Orlov, 陈四喜, Valeriia Aleksandrovna Baraniukova, Panagiotis Katsoris, Argiris Symeonidis	2023	1
6	Increased age-associated B cells in patients with acquired aplastic anemia correlate with IFN-γ Blood Advances ·Elena E. Solomou, Antonis Kattamis, Argiris Symeonidis, Chaido Sirinian, Hans Jacobs, Marianna Tzanoudaki, Panagiotis Diamantopoulos, A. V. Fofanov, K Hagiwara, Nikolaos Giannakoulas, Véronèse Lauren, Panagoula Κollia, Nora‐Athina Viniou, Athanasios Galanopoulos, Stamatis‐Nick C. Liossis, George Vassilopoulos	2023	2
7	Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists Blood Advances ·Juan Carlos Lozano M., Annette Conrads‐Frank, Ursula Rochau, Karin A. Koinig, Marjan Arvandi, J. Huston, Corine van Marrewijk, Pierre Fenaux, Argiris Symeonidis, Fatiha Chermat, Hege Garelius, David Bowen, Moshe Mittelman, Elvira Mora, Théo de Witte, Fabio Efficace, Uwe Siebert, Reinhard Stauder	2021	4
8	Subdiaphragmatic extranodal localizations at diagnosis of primary mediastinal large B-cell lymphoma: an impressive, rare presentation with no independent effect on prognosis Leukemia Research ·Robert F. Krauss, Sotirios G. Papageorgiou, Tameem Azzawi, Maria K. Angelopoulou, Christina Kalpadakis, 訾方, Eirini Katodritou, Maria Kotsopoulou, Ιoannis Kotsianidis, Eleftheria Hatzimichael, Edwin Tjandraatmadja, Anne Godde, 郭子瑞, Argiris Symeonidis, Maria Gavriatopoulou, Panayiotis Panayiotidis, Kostas Konstantopoulos, Efthymios Karmiris, Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos	2021	2
9	Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study SHILAP Revista de lepidopterología ·Konstantinos Liapis, Blenna Patterson, Vasileios Papadopoulos, Alexandra Kourakli, Athanasios Galanopoulos, Menelaos Papoutselis, Sotirios G. Papageorgiou, Panagiotis Diamantopoulos, Vassiliki Pappa, Nora‐Athina Viniou, Theodoros P. Vassilakopoulos, Eleftheria Hatzimichael, Gnoh Djnba OUATTARA, Werner Ecker, Charalampos Pontikoglou, Panayiotis Panayiotidis, Robert F. Krauss, Anna Vardi, Argiris Symeonidis, Ιoannis Kotsianidis	2020	2
10	Efficacy of Daratumumab with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment: An Interim Analysis of a Phase 2 Study (the DARE Study) Blood ·G R Arunoday, Evangelos Terpos, Argiris Symeonidis, Sosana Delimpasi, Michèle Cavo, Elena Zamagni, Eirini Katodritou, Barbara Gamberi, Marie‐Christine Kyrtsonis, Maria Gavriatopoulou, Μαρία Ρούσσου, Despina Fotiou, Evdoxia Hatjiharissi, Nikolaos Kanellias, Magdalini Migkou, Meletios Α. Dimopoulos	2019	0
11	Evolving Treatment Trends in Relapsed/Refractory Multiple Myeloma (RRMM) in Europe from 2016 to 2018: Analysis of a Multi-National Survey Blood ·Maximilian Merz, Isabelle Vande Broek, Куликов Максим Павлович, Brigitte Kolb, Argiris Symeonidis, Emmanouil Nikolousis, Athanasios Zomas, N. Moustakas, A. Godot, Hartmut Goldschmidt	2019	5
12	The prognostic value of monosomal karyotype (MK) in higher‐risk patients with myelodysplastic syndromes treated with 5‐Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group American Journal of Hematology ·Sotirios G. Papageorgiou, Diamantina Vasilatou, Christos K. Kontos, Ιoannis Kotsianidis, Argiris Symeonidis, Athanasios Galanopoulos, Eleftheria Hatzimichael, 成海宁, 陽右上野, Panagiotis Diamantopoulos, Theodoros P. Vassilakopoulos, Panagiotis Zikos, Helen Α. Papadaki, Masashi Kurabayashi, Gnoh Djnba OUATTARA, Panayiotis Panayiotidis, Nora‐Athina Viniou, Vassiliki Pappa	2018	9
13	The outcome of patients with high‐risk MDS achieving stable disease after treatment with 5‐azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group Hematological Oncology ·Sotirios G. Papageorgiou, Christos K. Kontos, Ιoannis Kotsianidis, Diamantina Vasilatou, Argiris Symeonidis, Athanasios Galanopoulos, د . دعاء الفجر محمد سامی, Eleftheria Hatzimichael, Panagiotis Repousis, Panagiotis Zikos, Nora‐Athina Viniou, 陽右上野, Theodoros P. Vassilakopoulos, Panagiotis Diamantopoulos, V. V. MASSOLA, Masashi Kurabayashi, Gnoh Djnba OUATTARA, Helen Α. Papadaki, Panayiotis Panayiotidis, Vasiliki Pappa	2018	7
14	The Prognostic Value of Monosomal Karyotype (MK) in High-Risk Patients with Myelodysplastic Syndromes Treated with 5-Azacitidine Blood ·Sotirios G. Papageorgiou, Christos K. Kontos, W. L. Prado da Silva, Hans Hermann Burchardt, Argiris Symeonidis, Athanasios Galanopoulos, Ιoannis Kotsianidis, Vassiliki Pappa	2017	1
15	Erythropoiesis‐stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower‐risk myelodysplastic syndrome Journal of Internal Medicine ·Bartsikhovs'ka Mp, W. Thomas Johnston, Alexandra Smith, Donna L. Watts, Louise de Swart, Pierre Fenaux, Argiris Symeonidis, Guillermo Sanz, Jaroslav Čermák, Reinhard Stauder, Luca Malcovati, Moshe Mittelman, Arjan A. van de Loosdrecht, Corine J. van Marrewijk, Cuihua Chen, Simon Crouch, T.J.M. de Witte, Eva Hellström‐Lindberg	2016	22
16	Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents Annals of Oncology ·Meletios Α. Dimopoulos, Sosana Delimpasi, Eirini Katodritou, Amalia Vassou, Maria‐Christina Kyrtsonis, Panagiotis Repousis, Zafiris Kartasis, Agapi Parcharidou, Michalis Michael, Eurydiki Michalis, Dimitra Gika, Argiris Symeonidis, Anastasia Pouli, Kostas Konstantopoulos, Evangelos Terpos, Efstathios Kastritis	2013	109
17	The role of iron and iron chelators in zygomycosis Clinical Microbiology and Infection ·Argiris Symeonidis	2009	45
18	Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of response Annals of Hematology ·Nora Viniou, Evangelos Terpos, Moulay-Lahssan Baya E, B Verachtert, Salem Akel, A D GUNN, Jasper Riebesehl, Despoina Georgiadou, Alexandra Kouraklis, Sugiyanta, Anies Tri Sulistyowati, Argiris Symeonidis, Nicolaos Anagnostopoulos, John Christakis, Anastasia Tasiopoulou, Dimitris Loukopoulos, Xenophon Yataganas	2002	5
19	Deformability of the Erythrocyte Membrane in Patients with Myelodysplastic Syndromes Acta Haematologica ·G. Athanassiou, Argiris Symeonidis, S. HAUSSÜHL, Y. F. Missirlis, Nicholas Zoumbos	1992	3
20	Prognostic significance of immune function parameters in patients with chronic lymphocytic leukaemia European Journal Of Haematology ·Leticia Martínez‐Ruano, Argiris Symeonidis, Nicholas Zoumbos	1990	24

About Argiris Symeonidis

Argiris Symeonidis is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Family Practice, having authored 179 papers that have together received 2.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (63 papers), Multiple Myeloma Research and Treatments (48 papers), Hemoglobinopathies and Related Disorders (31 papers), Peptidase Inhibition and Analysis (21 papers), Chronic Lymphocytic Leukemia Research (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers), Lymphoma Diagnosis and Treatment (18 papers) and Hematopoietic Stem Cell Transplantation (15 papers). The work is most often cited by research in Hematology (1.6k citations), Genetics (908 citations), Oncology (616 citations), Pathology and Forensic Medicine (364 citations) and Molecular Biology (847 citations). Argiris Symeonidis has collaborated with scholars based in Greece, Italy and France. Frequent co-authors include Meletios Α. Dimopoulos, Evangelos Terpos, Nicholas Zoumbos, Eirini Katodritou, Anastasia Pouli, Konstantinos Zervas, Dimitra Gika, Nikolaos Anagnostopoulos, Zafiris Kartasis and Efstathios Kastritis. Their work appears in journals such as Blood, Leukemia Research, European Journal Of Haematology, Acta Haematologica and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact